#wvcusa winner of the Best Prophylactic #Vaccine : Bexsero @Novartis Vaccines and Diagnostics

In Events (not on front page) by Marcia ArdilaLeave a Comment

 
Best Prophylactic vaccine world vaccine congress

The Best Prophylactic Vaccine (approved or in development) category was also open to all international Pharmaceutical, Biotech, Academic and Governmental organizations demonstrating a vaccine candidate that excels in its specific application.

The criteria used to judge this category will be as follows:

  • Vaccine candidate addresses current unmet medical needs
  • Candidate shows significant potential for vast geographical and market reach
  • Candidate possesses a novel mode of action or technology
  • Progress made to do date through clinical trials and / or achieved milestones
  • Advanced efficacy, safety and risk management data where appropriate

Winner: Bexsero – Novartis Vaccines and Diagnostics

 

Novartis_Vaccine_PMS
Judges specific comments on the winner included:

1. First vaccine to come out of a reverse vaccinology approach to antigen discovery. ie from genome to vaccine
2. A long awaited MenB vaccine with impressive clinical results across the majority of MenB strains

Well done Bexsero – Novartis Vaccines and Diagnostics

**********************************************************************

Highly Regarded' recommendation: sanofi pasteur's Clostridium Difficile Vaccine as this candiadate gave the eventual winner a real scare with the final scores, so well done sanofi pasteur.

Leave a Comment

Current ye@r *